Erratum: MicroRNA-124 suppresses the migration and invasion of osteosarcoma cells via targeting ROR2-mediated non-canonical Wnt signaling (Oncology Reports (2015) 34 (2195-2201) DOI: 10.3892/or.2015.4186);MicroRNA-124 suppresses the migration and invasion of osteosarcoma cells via targeting ROR2-mediated non-canonical Wnt signaling

Oncology Reports

Volumn 34, Issue 4, 2015, Pages 2195-2201

  Zhang, Can ^a   Hu, Yihe ^a   Wan, Jun ^a   He, Hongbo ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Invasion; MicroRNA 124; Migration; Osteosarcoma; Receptor tyrosine kinaselike orphan receptor 2

Indexed keywords

MICRORNA 124; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR 2; UNCLASSIFIED DRUG; WNT PROTEIN; 3' UNTRANSLATED REGION; MICRORNA; MIRN124 MICRORNA, HUMAN; ROR2 PROTEIN, HUMAN;

ARTICLE; CANCER INHIBITION; CELL INVASION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; METASTASIS INHIBITION; MIGRATION INHIBITION; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROR2 GENE; TUMOR INVASION; UPREGULATION; WNT SIGNALING PATHWAY; 3' UNTRANSLATED REGION; BONE TUMOR; CELL MOTION; CELL PROLIFERATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; OSTEOSARCOMA; RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTORS; WNT SIGNALING PATHWAY;

EID: 84939188065     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2021.8107     Document Type: Erratum

References (31)

1. Thompson LD: Osteosarcoma. Ear Nose Throat J 92: 288-290, 2013.
2. Liang W, Gao B, Fu P, Xu S, Qian Y and Fu Q: The miRNAs in the pathgenesis of osteosarcoma. Front Biosci (Landmark Ed) 18: 788-794, 2013.
3. Moss EG: MicroRNAs: Hidden in the genome. Curr Biol 12: R138-R140, 2002.
4. Shen L, Wang P, Yang J and Li X: MicroRNA-217 regulates WASF3 expression and suppresses tumor growth and metastasis in osteosarcoma. PLoS One 9: e109138, 2014.
5. Wang Q, Cai J, Wang J, Xiong C and Zhao J: MIR-143 inhibits EGFR-signaling-dependent osteosarcoma invasion. Tumour Biol 35: 12743-12748, 2014.
6. Jiang L, He A, Zhang Q and Tao C: MIR-126 inhibits cell growth, invasion, and migration of osteosarcoma cells by downregulating ADAM-9. Tumour Biol 35: 12645-12654, 2014.
7. Zhang K, Zhang Y, Ren K, Zhao G, Yan K and Ma B: MicroRNA-101 inhibits the metastasis of osteosarcoma cells by downregulation of EZH2 expression. Oncol Rep 32: 2143-2149, 2014.
8. Han K, Zhao T, Chen X, Bian N, Yang T, Ma Q, Cai C, Fan Q, Zhou Y and Ma B: microRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R. Int J Oncol 45: 1437-1449, 2014.
9. Yang J and Zhang W: New molecular insights into osteosarcoma targeted therapy. Curr Opin Oncol 25: 398-406, 2013.
10. Sundaram MV: Canonical RTK-Ras-ERK signaling and related alternative pathways. Jul 11, 2013: 1-38. doi: 10.1895/wormbook.1.80.2.
11. Jiménez G, Shvartsman SY and Paroush Z: The Capicua repressor-a general sensor of RTK signaling in development and disease. J Cell Sci 125: 1383-1391, 2012.
12. Batchu SN and Korshunov VA: Novel tyrosine kinase signaling pathways: Implications in vascular remodeling. Curr Opin Nephrol Hypertens 21: 122-127, 2012.
13. DeChiara TM, Kimble RB, Poueymirou WT, Rojas J, Masiakowski P, Valenzuela DM and Yancopoulos GD: Ror2, encoding a receptor-like tyrosine kinase, is required for cartilage and growth plate development. Nat Genet 24: 271-274, 2000.
14. Mehawej C, Chouery E, Maalouf D, Baujat G, Le Merrer M, Cormier-Daire V and Mégarbané A: Identification of a novel causative mutation in the ROR2 gene in a Lebanese family with a mild form of recessive Robinow syndrome. Eur J Med Genet 55: 103-108, 2012.
15. Lu BJ, Wang YQ, Wei XJ, Rong LQ, Wei D, Yan CM, Wang DJ and Sun JY: Expression of WNT-5a and ROR2 correlates with disease severity in osteosarcoma. Mol Med Rep 5: 1033-1036, 2012.
16. Ren D, Minami Y and Nishita M: Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelial-mesenchymal transition. Genes Cells 16: 304-315, 2011.
17. Enomoto M, Hayakawa S, Itsukushima S, Ren DY, Matsuo M, Tamada K, Oneyama C, Okada M, Takumi T, Nishita M, et al: Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling. Oncogene 28: 3197-3208, 2009.
18. Liang YJ, Wang QY, Zhou CX, Yin QQ, He M, Yu XT, Cao DX, Chen GQ, He JR and Zhao Q: MIR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer. Carcinogenesis 34: 713-722, 2013.
19. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I and Inazawa J: MIR-124 and MIR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 31: 766-776, 2010.
20. An L, Liu Y, Wu A and Guan Y: microRNA-124 inhibits migration and invasion by down-regulating ROCK1 in glioma. PLoS One 8: e69478, 2013.
21. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
22. He Y, Meng C, Shao Z, Wang H and Yang S: MIR-23a functions as a tumor suppressor in osteosarcoma. Cell Physiol Biochem 34: 1485-1496, 2014.
23. Zhang F, Huang W, Sheng M and Liu T: MIR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients. Tumour Biol 36: 2041-2048, 2015.
24. Lin S, Shao NN, Fan L, Ma XC, Pu FF and Shao ZW: Effect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR. J Huazhong Univ Sci Technolog Med Sci 34: 889-895, 2014.
25. Han G, Wang Y, Bi W, Jia J and Wang W: MicroRNA-124 functions as a tumor suppressor and indicates prognosis in human osteosarcoma. Exp Ther Med 9: 679-684, 2015.
26. Geng S, Zhang X, Chen J, Liu X, Zhang H, Xu X, Ma Y, Li B, Zhang Y, Bi Z, et al: The tumor suppressor role of MIR-124 in osteosarcoma. PLoS One 9: e91566, 2014.
27. Stricker S and Mundlos S: FGF and ROR2 receptor tyrosine kinase signaling in human skeletal development. Curr Top Dev Biol 97: 179-206, 2011.
28. Liu Y, Bhat RA, Seestaller-Wehr LM, Fukayama S, Mangine A, Moran RA, Komm BS, Bodine PV and Billiard J: The orphan receptor tyrosine kinase Ror2 promotes osteoblast differentiation and enhances ex vivo bone formation. Mol Endocrinol 21: 376-387, 2007.
29. Liu Y, Ross JF, Bodine PV and Billiard J: Homodimerization of Ror2 tyrosine kinase receptor induces 14-3-3(beta) phosphorylation and promotes osteoblast differentiation and bone formation. Mol Endocrinol 21: 3050-3061, 2007.
30. Yamagata K, Li X, Ikegaki S, Oneyama C, Okada M, Nishita M and Minami Y: Dissection of Wnt5a-Ror2 signaling leading to matrix metalloproteinase (MMP-13) expression. J Biol Chem 287: 1588-1599, 2012.
31. Morioka K, Tanikawa C, Ochi K, Daigo Y, Katagiri T, Kawano H, Kawaguchi H, Myoui A, Yoshikawa H, Naka N, et al: Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma. Cancer Sci 100: 1227-1233, 2009.